Literature DB >> 27215536

Mechanisms linking electrical alternans and clinical ventricular arrhythmia in human heart failure.

J D Bayer1, G G Lalani2, E J Vigmond3, S M Narayan4, N A Trayanova5.   

Abstract

BACKGROUND: Mechanisms of ventricular tachycardia (VT) and ventricular fibrillation (VF) in patients with heart failure (HF) are undefined.
OBJECTIVE: The purpose of this study was to elucidate VT/VF mechanisms in HF by using a computational-clinical approach.
METHODS: In 53 patients with HF and 18 control patients, we established the relationship between low-amplitude action potential voltage alternans (APV-ALT) during ventricular pacing at near-resting heart rates and VT/VF on long-term follow-up. Mechanisms underlying the transition of APV-ALT to VT/VF, which cannot be ascertained in patients, were dissected with multiscale human ventricular models based on human electrophysiological and magnetic resonance imaging data (control and HF).
RESULTS: For patients with APV-ALT k-score >1.7, complex action potential duration (APD) oscillations (≥2.3% of mean APD), rather than APD alternans, most accurately predicted VT/VF during long-term follow-up (+82%; -90% predictive values). In the failing human ventricular models, abnormal sarcoplasmic reticulum (SR) calcium handling caused APV-ALT (>1 mV) during pacing with a cycle length of 550 ms, which transitioned into large magnitude (>100 ms) discordant repolarization time alternans (RT-ALT) at faster rates. This initiated VT/VF (cycle length <400 ms) by steepening apicobasal repolarization (189 ms/mm) until unidirectional conduction block and reentry. Complex APD oscillations resulted from nonstationary discordant RT-ALT. Restoring SR calcium to control levels was antiarrhythmic by terminating electrical alternans.
CONCLUSION: APV-ALT and complex APD oscillations at near-resting heart rates in patients with HF are linked to arrhythmogenic discordant RT-ALT. This may enable novel physiologically tailored, bioengineered indices to improve VT/VF risk stratification, where SR calcium handling and spatial apicobasal repolarization are potential therapeutic targets.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alternans; Arrhythmia; Computational modeling; Heart failure; Simulation

Mesh:

Substances:

Year:  2016        PMID: 27215536      PMCID: PMC4996715          DOI: 10.1016/j.hrthm.2016.05.017

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  22 in total

1.  Cardiac alternans do not rely on diastolic sarcoplasmic reticulum calcium content fluctuations.

Authors:  Eckard Picht; Jaime DeSantiago; Lothar A Blatter; Donald M Bers
Journal:  Circ Res       Date:  2006-08-31       Impact factor: 17.367

2.  Spatially discordant alternans in cardiac tissue: role of calcium cycling.

Authors:  Daisuke Sato; Yohannes Shiferaw; Alan Garfinkel; James N Weiss; Zhilin Qu; Alain Karma
Journal:  Circ Res       Date:  2006-08-10       Impact factor: 17.367

3.  Dynamic origin of spatially discordant alternans in cardiac tissue.

Authors:  Hideki Hayashi; Yohannes Shiferaw; Daisuke Sato; Motoki Nihei; Shien-Fong Lin; Peng-Sheng Chen; Alan Garfinkel; James N Weiss; Zhilin Qu
Journal:  Biophys J       Date:  2006-10-27       Impact factor: 4.033

4.  Optical mapping of sarcoplasmic reticulum Ca2+ in the intact heart: ryanodine receptor refractoriness during alternans and fibrillation.

Authors:  Lianguo Wang; Rachel C Myles; Nicole M De Jesus; Alex K P Ohlendorf; Donald M Bers; Crystal M Ripplinger
Journal:  Circ Res       Date:  2014-02-25       Impact factor: 17.367

5.  Repolarization alternans reveals vulnerability to human atrial fibrillation.

Authors:  Sanjiv M Narayan; Michael R Franz; Paul Clopton; Etienne J Pruvot; David E Krummen
Journal:  Circulation       Date:  2011-06-06       Impact factor: 29.690

6.  Progressive increases in complexity of T-wave oscillations herald ischemia-induced ventricular fibrillation.

Authors:  Bruce D Nearing; Richard L Verrier
Journal:  Circ Res       Date:  2002-10-18       Impact factor: 17.367

7.  Conduction remodeling in human end-stage nonischemic left ventricular cardiomyopathy.

Authors:  Alexey V Glukhov; Vadim V Fedorov; Paul W Kalish; Vinod K Ravikumar; Qing Lou; Deborah Janks; Richard B Schuessler; Nader Moazami; Igor R Efimov
Journal:  Circulation       Date:  2012-03-12       Impact factor: 29.690

8.  Mechanism linking T-wave alternans to the genesis of cardiac fibrillation.

Authors:  J M Pastore; S D Girouard; K R Laurita; F G Akar; D S Rosenbaum
Journal:  Circulation       Date:  1999-03-16       Impact factor: 29.690

9.  Transmural dispersion of repolarization in failing and nonfailing human ventricle.

Authors:  Alexey V Glukhov; Vadim V Fedorov; Qing Lou; Vinod K Ravikumar; Paul W Kalish; Richard B Schuessler; Nader Moazami; Igor R Efimov
Journal:  Circ Res       Date:  2010-01-21       Impact factor: 17.367

Review 10.  Dispersion in ventricular repolarization in the human, canine and porcine heart.

Authors:  Tobias Opthof; Michiel J Janse; Veronique M F Meijborg; Juan Cinca; Michael R Rosen; Ruben Coronel
Journal:  Prog Biophys Mol Biol       Date:  2016-01-11       Impact factor: 3.667

View more
  11 in total

1.  Computational Identification of Ventricular Arrhythmia Risk in Pediatric Myocarditis.

Authors:  Mark J Cartoski; Plamen P Nikolov; Adityo Prakosa; Patrick M Boyle; Philip J Spevak; Natalia A Trayanova
Journal:  Pediatr Cardiol       Date:  2019-03-06       Impact factor: 1.655

Review 2.  How personalized heart modeling can help treatment of lethal arrhythmias: A focus on ventricular tachycardia ablation strategies in post-infarction patients.

Authors:  Natalia A Trayanova; Ashish N Doshi; Adityo Prakosa
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-01-09

3.  Spatiotemporal characterization of the transition from sinus rhythm to ventricular fibrillation during an acute ischemic event in the intact human heart by whole-heart sock-mapping.

Authors:  Michele Orini; Peter Taggart; Martin Hayward; Pier D Lambiase
Journal:  HeartRhythm Case Rep       Date:  2017-02-20

4.  Machine Learned Cellular Phenotypes in Cardiomyopathy Predict Sudden Death.

Authors:  Albert J Rogers; Anojan Selvalingam; Mahmood I Alhusseini; David E Krummen; Cesare Corrado; Firas Abuzaid; Tina Baykaner; Christian Meyer; Paul Clopton; Wayne Giles; Peter Bailis; Steven Niederer; Paul J Wang; Wouter-Jan Rappel; Matei Zaharia; Sanjiv M Narayan
Journal:  Circ Res       Date:  2020-11-10       Impact factor: 17.367

5.  β-Adrenergic receptor stimulation inhibits proarrhythmic alternans in postinfarction border zone cardiomyocytes: a computational analysis.

Authors:  Jakub Tomek; Blanca Rodriguez; Gil Bub; Jordi Heijman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-05-26       Impact factor: 4.733

6.  Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.

Authors:  Jie Liu; Jason D Bayer; Roozbeh Aschar-Sobbi; Marianne Wauchop; Danna Spears; Michael Gollob; Edward J Vigmond; Robert Tsushima; Peter H Backx; Vijay S Chauhan
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

7.  Personalized Imaging and Modeling Strategies for Arrhythmia Prevention and Therapy.

Authors:  Natalia A Trayanova; Patrick M Boyle; Plamen P Nikolov
Journal:  Curr Opin Biomed Eng       Date:  2018-03

Review 8.  Computational models in cardiology.

Authors:  Steven A Niederer; Joost Lumens; Natalia A Trayanova
Journal:  Nat Rev Cardiol       Date:  2019-02       Impact factor: 32.419

9.  Learning for Prevention of Sudden Cardiac Death.

Authors:  Natalia A Trayanova
Journal:  Circ Res       Date:  2021-01-21       Impact factor: 17.367

10.  Modulation of Cardiac Alternans by Altered Sarcoplasmic Reticulum Calcium Release: A Simulation Study.

Authors:  Jakub Tomek; Markéta Tomková; Xin Zhou; Gil Bub; Blanca Rodriguez
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.